Both in Pharmaceuticals
Impact BioMedical vs Elicio Therapeutics
Over the past year IBO returned −32.4% and ELTX returned −82.9%; their daily moves had a correlation of 0.00.
IBO −32.4% ELTX −82.9%Growth of $1, one year, split-adjusted
| Metric | IBO | ELTX |
|---|---|---|
| Price | $5.61 | $1.85 |
| Market cap | $47.9M | $48.6M |
| Today | −1.41% | +0.54% |
| 1 month | +0.8% | −38.3% |
| 6 months | −22.7% | −82.3% |
| Year to date | −12.0% | −76.8% |
| 1 year | −31.4% | −82.9% |
| Revenue growth (YoY) | −57.1% | — |
| Gross margin | −533.3% | — |
| Net margin | −23300.0% | — |
| P/E (TTM) | 60.7× | — |
| Price / sales | 1,369.4× | — |
| Net cash | $10.0K | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 732.1% | 76.4% |
| Short % of float | 4.5% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).